The economic burden of psoriatic diseases in Taiwan

Kuan Chen Chen, Sheng Tzu Hung, Ching Wen Wendy Yang, Tsen Fang Tsai, Chao Hsiun Tang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Psoriasis is associated with significant economic burdens. Data regarding costs for psoriasis patients in Taiwan are not available. Objective: To estimate the economic burden of psoriasis in Taiwan. Methods: Psoriasis patients and their controls were identified from the 2006 National Health Insurance (NHI) research database, and differences in annual healthcare utilization and costs between psoriasis cases and controls were predicted by two-part models and generalized linear models. Face-to-face interviews were conducted in five hospital settings to collect information on out-of-pocket payments and productivity losses associated with seeking care. All analyses were stratified by the severity level of psoriasis. Results: From the payer's perspective, the NHI cost associated with moderate to severe psoriasis (sPsO) was NT$41,525 and that with mild psoriasis (mPsO) was NT$14,816. Adding the out-of-pocket payments (NT$13,095 for sPsO and NT$7237 for mPsO) and the loss of productivity (NT$6203 for sPsO and NT$2750 for mPsO), the annual total cost for sPsO was NT$60,823 and that for mPsO was NT$24,803. Conclusion: Psoriasis is associated with significant economic burdens in Taiwan. Effective treatment of the disease could produce substantial savings in healthcare resources and gains in productivity.

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalJournal of Dermatological Science
Volume75
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Cost of Illness
Taiwan
Psoriasis
Health insurance
Economics
Productivity
Costs
National Health Programs
Health Expenditures
Health Care Costs
Costs and Cost Analysis

Keywords

  • Cost-of-illness
  • Economic burdens
  • National Health Insurance
  • Psoriasis
  • Taiwan

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Molecular Biology
  • Medicine(all)

Cite this

The economic burden of psoriatic diseases in Taiwan. / Chen, Kuan Chen; Hung, Sheng Tzu; Yang, Ching Wen Wendy; Tsai, Tsen Fang; Tang, Chao Hsiun.

In: Journal of Dermatological Science, Vol. 75, No. 3, 2014, p. 183-189.

Research output: Contribution to journalArticle

Chen, Kuan Chen ; Hung, Sheng Tzu ; Yang, Ching Wen Wendy ; Tsai, Tsen Fang ; Tang, Chao Hsiun. / The economic burden of psoriatic diseases in Taiwan. In: Journal of Dermatological Science. 2014 ; Vol. 75, No. 3. pp. 183-189.
@article{72e84c62b20b4ad28f301db680547f52,
title = "The economic burden of psoriatic diseases in Taiwan",
abstract = "Background: Psoriasis is associated with significant economic burdens. Data regarding costs for psoriasis patients in Taiwan are not available. Objective: To estimate the economic burden of psoriasis in Taiwan. Methods: Psoriasis patients and their controls were identified from the 2006 National Health Insurance (NHI) research database, and differences in annual healthcare utilization and costs between psoriasis cases and controls were predicted by two-part models and generalized linear models. Face-to-face interviews were conducted in five hospital settings to collect information on out-of-pocket payments and productivity losses associated with seeking care. All analyses were stratified by the severity level of psoriasis. Results: From the payer's perspective, the NHI cost associated with moderate to severe psoriasis (sPsO) was NT$41,525 and that with mild psoriasis (mPsO) was NT$14,816. Adding the out-of-pocket payments (NT$13,095 for sPsO and NT$7237 for mPsO) and the loss of productivity (NT$6203 for sPsO and NT$2750 for mPsO), the annual total cost for sPsO was NT$60,823 and that for mPsO was NT$24,803. Conclusion: Psoriasis is associated with significant economic burdens in Taiwan. Effective treatment of the disease could produce substantial savings in healthcare resources and gains in productivity.",
keywords = "Cost-of-illness, Economic burdens, National Health Insurance, Psoriasis, Taiwan",
author = "Chen, {Kuan Chen} and Hung, {Sheng Tzu} and Yang, {Ching Wen Wendy} and Tsai, {Tsen Fang} and Tang, {Chao Hsiun}",
year = "2014",
doi = "10.1016/j.jdermsci.2014.05.012",
language = "English",
volume = "75",
pages = "183--189",
journal = "Journal of Dermatological Science",
issn = "0923-1811",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - The economic burden of psoriatic diseases in Taiwan

AU - Chen, Kuan Chen

AU - Hung, Sheng Tzu

AU - Yang, Ching Wen Wendy

AU - Tsai, Tsen Fang

AU - Tang, Chao Hsiun

PY - 2014

Y1 - 2014

N2 - Background: Psoriasis is associated with significant economic burdens. Data regarding costs for psoriasis patients in Taiwan are not available. Objective: To estimate the economic burden of psoriasis in Taiwan. Methods: Psoriasis patients and their controls were identified from the 2006 National Health Insurance (NHI) research database, and differences in annual healthcare utilization and costs between psoriasis cases and controls were predicted by two-part models and generalized linear models. Face-to-face interviews were conducted in five hospital settings to collect information on out-of-pocket payments and productivity losses associated with seeking care. All analyses were stratified by the severity level of psoriasis. Results: From the payer's perspective, the NHI cost associated with moderate to severe psoriasis (sPsO) was NT$41,525 and that with mild psoriasis (mPsO) was NT$14,816. Adding the out-of-pocket payments (NT$13,095 for sPsO and NT$7237 for mPsO) and the loss of productivity (NT$6203 for sPsO and NT$2750 for mPsO), the annual total cost for sPsO was NT$60,823 and that for mPsO was NT$24,803. Conclusion: Psoriasis is associated with significant economic burdens in Taiwan. Effective treatment of the disease could produce substantial savings in healthcare resources and gains in productivity.

AB - Background: Psoriasis is associated with significant economic burdens. Data regarding costs for psoriasis patients in Taiwan are not available. Objective: To estimate the economic burden of psoriasis in Taiwan. Methods: Psoriasis patients and their controls were identified from the 2006 National Health Insurance (NHI) research database, and differences in annual healthcare utilization and costs between psoriasis cases and controls were predicted by two-part models and generalized linear models. Face-to-face interviews were conducted in five hospital settings to collect information on out-of-pocket payments and productivity losses associated with seeking care. All analyses were stratified by the severity level of psoriasis. Results: From the payer's perspective, the NHI cost associated with moderate to severe psoriasis (sPsO) was NT$41,525 and that with mild psoriasis (mPsO) was NT$14,816. Adding the out-of-pocket payments (NT$13,095 for sPsO and NT$7237 for mPsO) and the loss of productivity (NT$6203 for sPsO and NT$2750 for mPsO), the annual total cost for sPsO was NT$60,823 and that for mPsO was NT$24,803. Conclusion: Psoriasis is associated with significant economic burdens in Taiwan. Effective treatment of the disease could produce substantial savings in healthcare resources and gains in productivity.

KW - Cost-of-illness

KW - Economic burdens

KW - National Health Insurance

KW - Psoriasis

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=84905019261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905019261&partnerID=8YFLogxK

U2 - 10.1016/j.jdermsci.2014.05.012

DO - 10.1016/j.jdermsci.2014.05.012

M3 - Article

C2 - 24953536

AN - SCOPUS:84905019261

VL - 75

SP - 183

EP - 189

JO - Journal of Dermatological Science

JF - Journal of Dermatological Science

SN - 0923-1811

IS - 3

ER -